Muna Therapeutics ApS: Financial statements 2021
CVR: 41142871
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
Muna Therapeutics ApS (CVR 41142871) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK -49,692,746 and a net result of DKK -61,518,260 compared with DKK -7,382,109 the year before. Equity in the 2021 report amounted to DKK 162,312,987. The solvency ratio was 88.2%. The company had 7 employees in the financial year.
- Gross Profit
- DKK -49,692,746
- Profit/Loss
- DKK -61,518,260
- Equity
- DKK 162,312,987
- Total Assets
- DKK 184,063,685
- Employees
- 7
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | -49.7 mio. | -61.5 mio. | 162.3 mio. | 7 |
| 2020 | - | -7.3 mio. | -7.4 mio. | 16.7 mio. | 3 |
Official annual report
Find more companies like Muna Therapeutics ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of September 15, 2021, Morten Døssing has joined the board of directors of Muna Therapeutics ApS.
As of September 15, 2021, Donald William Nicholson has joined the board of directors of Muna Therapeutics ApS.
As of September 14, 2021, Morten Døssing has left the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Henrijette Elsebeth Richter has joined the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Rita Balice-Gordon has joined the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Cillian King has joined the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Luc Dochez has joined the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Laia Crespo-Martin has joined the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Isaac Ciechanover has joined the board of directors of Muna Therapeutics ApS.
As of July 8, 2021, Anders Mørkeberg Hinsby has left the board of directors of Muna Therapeutics ApS.
About Muna Therapeutics ApS
Muna Therapeutics ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske præparater. The management consists of Michel Marcel A. Detheux. The board consists of Donald William Nicholson (chair), Camilla Petrycer Hansen, Cillian King and Eileen Elizabeth McGuire. The company's owners include Novo Holdings A/S, Sanofi Foreign Participations B.V. and Axxam S.p.A.. The company has 18 employees (2026). In 2025, the company reported a gross profit of DKK -60,636,000 and a net result of DKK -125,695,000 compared with DKK -173,625,357 the year before. Equity in the 2025 report amounted to DKK -120,338,000.